The NMCR Challenging Cases® series is the premier market research engine for both qualitative and quantitative assessments in the field of hematology and oncology. As such, we are the leader in case based behavioral research. Both the innovative methodology and the consulting panel that participates in the research series are proprietary to Xcenda.
What makes the NMCR Challenging Cases research environment unique?
Physicians “think” on a patient-by-patient basis, and research performed in this manner mimics the clinical experience, thus providing our clients with insight to the relevant decision factors in patient care. Consultant input is acquired anonymously and contemporaneously, thus avoiding “group think” and “snowballing.” Each research series is a multicompany platform and is arranged by tumor types.
The case-based format is superior for clients who need to identify:
Current tumor areas of study include but are not limited to:
Who are the members of Xcenda’s proprietary research panel who participate in the NMCR Challenging Cases series?
Debrief session
Included at each NMCR Challenging Cases market research event, the debrief session provides the opportunity for clients to conduct further research with a subset of providers using a focus group-style format. Clients can conduct in-depth, qualitative discussion and analysis to understand the “what” and “why” of topics presented earlier in the day.
When and where are the NMCR Challenging Cases events held?
The events are conveniently scheduled in major metropolitan areas across the US on Saturdays from 8 am to 3 pm. View the calendar of market research events.
Manufacturers, please contact Tim McGee
Physicians, please contact Natalie Gysin
“The Challenging Cases debrief meetings allow physicians to voice their interpretations of clinical data and company messages in a forum with their peers. The feedback helped confirm assumptions we had made on treatment paradigms, but also understand new approaches we hadn’t considered.”
- Senior Product Manager, biotechnology firm